A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
Clinical trial NCT04806945 · WITHDRAWN
Trial details
- NCT number
- NCT04806945
- Sponsor
- Shanghai Henlius Biotech
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-02-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.